BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 30924024)

  • 1. Emodin induced necroptosis in the glioma cell line U251 via the TNF-α/RIP1/RIP3 pathway.
    Zhou J; Li G; Han G; Feng S; Liu Y; Chen J; Liu C; Zhao L; Jin F
    Invest New Drugs; 2020 Feb; 38(1):50-59. PubMed ID: 30924024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shikonin induces glioma cell necroptosis in vitro by ROS overproduction and promoting RIP1/RIP3 necrosome formation.
    Lu B; Gong X; Wang ZQ; Ding Y; Wang C; Luo TF; Piao MH; Meng FK; Chi GF; Luo YN; Ge PF
    Acta Pharmacol Sin; 2017 Nov; 38(11):1543-1553. PubMed ID: 28816233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of celastrol derivatives as potential anti-glioma agents by activating RIP1/RIP3/MLKL pathway to induce necroptosis.
    Feng Y; Wang W; Zhang Y; Fu X; Ping K; Zhao J; Lei Y; Mou Y; Wang S
    Eur J Med Chem; 2022 Feb; 229():114070. PubMed ID: 34968902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RIP1, RIP3, and MLKL Contribute to Cell Death Caused by Clostridium perfringens Enterotoxin.
    Shrestha A; Mehdizadeh Gohari I; McClane BA
    mBio; 2019 Dec; 10(6):. PubMed ID: 31848291
    [No Abstract]   [Full Text] [Related]  

  • 5. Cytosolic calcium mediates RIP1/RIP3 complex-dependent necroptosis through JNK activation and mitochondrial ROS production in human colon cancer cells.
    Sun W; Wu X; Gao H; Yu J; Zhao W; Lu JJ; Wang J; Du G; Chen X
    Free Radic Biol Med; 2017 Jul; 108():433-444. PubMed ID: 28414098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PI3K mediates tumor necrosis factor induced-necroptosis through initiating RIP1-RIP3-MLKL signaling pathway activation.
    Hu S; Chang X; Zhu H; Wang D; Chen G
    Cytokine; 2020 May; 129():155046. PubMed ID: 32114297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RIP1 and RIP3 contribute to shikonin-induced DNA double-strand breaks in glioma cells via increase of intracellular reactive oxygen species.
    Zhou Z; Lu B; Wang C; Wang Z; Luo T; Piao M; Meng F; Chi G; Luo Y; Ge P
    Cancer Lett; 2017 Apr; 390():77-90. PubMed ID: 28108311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol inhibits necroptosis by mediating the TNF-α/RIP1/RIP3/MLKL pathway in myocardial hypoxia/reoxygenation injury.
    Hu Y; Pan H; Peng J; He J; Tang M; Yan S; Rong J; Li J; Zheng Z; Wang H; Liu Y; Zhong X
    Acta Biochim Biophys Sin (Shanghai); 2021 Mar; 53(4):430-437. PubMed ID: 33686403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GSK872 and necrostatin-1 protect retinal ganglion cells against necroptosis through inhibition of RIP1/RIP3/MLKL pathway in glutamate-induced retinal excitotoxic model of glaucoma.
    Liu M; Li H; Yang R; Ji D; Xia X
    J Neuroinflammation; 2022 Oct; 19(1):262. PubMed ID: 36289519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracts derived from a traditional Chinese herbal formula triggers necroptosis in ectocervical Ect1/E6E7 cells through activation of RIP1 kinase.
    Chen X; Hu X; Liu L; Liang X; Xiao J
    J Ethnopharmacol; 2019 Jul; 239():111922. PubMed ID: 31034957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anti-tumor effect of shikonin on osteosarcoma by inducing RIP1 and RIP3 dependent necroptosis.
    Fu Z; Deng B; Liao Y; Shan L; Yin F; Wang Z; Zeng H; Zuo D; Hua Y; Cai Z
    BMC Cancer; 2013 Dec; 13():580. PubMed ID: 24314238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitizing acute myeloid leukemia cells to induced differentiation by inhibiting the RIP1/RIP3 pathway.
    Xin J; You D; Breslin P; Li J; Zhang J; Wei W; Cannova J; Volk A; Gutierrez R; Xiao Y; Ni A; Ng G; Schmidt R; Xia Z; Pan J; Chen H; Patel MM; Kuo PC; Nand S; Kini AR; Zhang J; Chen J; Zhu J; Zhang J
    Leukemia; 2017 May; 31(5):1154-1165. PubMed ID: 27748372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Necroptosis regulates tumor repopulation after radiotherapy via RIP1/RIP3/MLKL/JNK/IL8 pathway.
    Wang Y; Zhao M; He S; Luo Y; Zhao Y; Cheng J; Gong Y; Xie J; Wang Y; Hu B; Tian L; Liu X; Li C; Huang Q
    J Exp Clin Cancer Res; 2019 Nov; 38(1):461. PubMed ID: 31706322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RIP1 and RIP3 contribute to shikonin-induced glycolysis suppression in glioma cells via increase of intracellular hydrogen peroxide.
    Lu B; Wang Z; Ding Y; Wang X; Lu S; Wang C; He C; Piao M; Chi G; Luo Y; Ge P
    Cancer Lett; 2018 Jul; 425():31-42. PubMed ID: 29608987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RIP1/RIP3-regulated necroptosis as a target for multifaceted disease therapy (Review).
    Liu Y; Liu T; Lei T; Zhang D; Du S; Girani L; Qi D; Lin C; Tong R; Wang Y
    Int J Mol Med; 2019 Sep; 44(3):771-786. PubMed ID: 31198981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRAF2 inhibits TRAIL- and CD95L-induced apoptosis and necroptosis.
    Karl I; Jossberger-Werner M; Schmidt N; Horn S; Goebeler M; Leverkus M; Wajant H; Giner T
    Cell Death Dis; 2014 Oct; 5(10):e1444. PubMed ID: 25299769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smac mimetic triggers necroptosis in pancreatic carcinoma cells when caspase activation is blocked.
    Hannes S; Abhari BA; Fulda S
    Cancer Lett; 2016 Sep; 380(1):31-8. PubMed ID: 27267809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HS-173 as a novel inducer of RIP3-dependent necroptosis in lung cancer.
    Park JH; Jung KH; Kim SJ; Yoon YC; Yan HH; Fang Z; Lee JE; Lim JH; Mah S; Hong S; Kim YS; Hong SS
    Cancer Lett; 2019 Mar; 444():94-104. PubMed ID: 30583075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Necrostatin-1 Protects Against Paraquat-Induced Cardiac Contractile Dysfunction via RIP1-RIP3-MLKL-Dependent Necroptosis Pathway.
    Zhang L; Feng Q; Wang T
    Cardiovasc Toxicol; 2018 Aug; 18(4):346-355. PubMed ID: 29299822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bufalin engages in RIP1-dependent and ROS-dependent programmed necroptosis in breast cancer cells by targeting the RIP1/RIP3/PGAM5 pathway.
    Li Y; Gong P; Kong C; Tian X
    Anticancer Drugs; 2019 Aug; 30(7):e0770. PubMed ID: 30829654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.